Traders Friendly Traders Friendly
  • Home
  • Latest News
  • Privacy Policy
  • Whitelisting
  1. Home
  2. Latest News
  3. The Case for Holding—Not Selling—GE’s Healthcare Stock
 The Case for Holding—Not Selling—GE’s Healthcare Stock
Latest News

The Case for Holding—Not Selling—GE’s Healthcare Stock

by January 7, 2023 0 Comment

The Case for Holding—Not Selling—GE’s Healthcare Stock | Barron’s

A healthcare giant has been born:


General Electric

completed the spinoff of its healthcare business,


GE HealthCare Technologies

on Wednesday, with the shares trading on the Nasdaq under the ticker GEHC.

GE investors face a choice: keep shares in the healthcare business they received in the spinoff, or cash out. GE HealthCare shares closed at $60.49 on Wednesday, up about 8%, and GE traded at $70.20, off about 17%. GE shareholders got one share of GE HealthCare for every three GE shares held, meaning that roughly $20 a share in GE stock value is now represented by GE HealthCare shares. Putting GE HealthCare back into GE gets investors $90.36 for the value of all GE investments. GE shares closed at $84.98 on Tuesday, so investors’ total stake in GE investments rose about 6% on Wednesday—not bad.

Previous post
Next post

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Copyright 2023. All Right Reserved By www.tradersfriendly.com